Stefano Toldo Selected Research

alpha 1-Antitrypsin (alpha 1 Antitrypsin)

1/2018	Inhibiting the Inflammatory Injury After Myocardial Ischemia Reperfusion With Plasma-Derived Alpha-1 Antitrypsin: A Post Hoc Analysis of the VCU-α1RT Study.
5/2017	A Preclinical Translational Study of the Cardioprotective Effects of Plasma-Derived Alpha-1 Anti-trypsin in Acute Myocardial Infarction.
1/2015	Effects of Prolastin C (Plasma-Derived Alpha-1 Antitrypsin) on the acute inflammatory response in patients with ST-segment elevation myocardial infarction (from the VCU-alpha 1-RT pilot study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Toldo Research Topics

Disease

31	Myocardial Infarction 06/2021 - 04/2009
23	Infarction (Infarctions) 01/2022 - 04/2009
20	Heart Failure 01/2022 - 04/2009
16	Ischemia 01/2022 - 08/2011
15	Reperfusion Injury 11/2021 - 10/2012
14	Inflammation (Inflammations) 01/2022 - 12/2011
11	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 09/2009
8	Left Ventricular Dysfunction 06/2021 - 01/2012
6	Fibrosis (Cirrhosis) 01/2022 - 05/2011
6	Hypertrophy 01/2022 - 04/2010
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2014
5	Infections 02/2021 - 01/2019
5	Brain Death (Brain Dead) 01/2021 - 01/2020
4	Heart Diseases (Heart Disease) 02/2021 - 10/2013
3	Cardiomyopathies (Cardiomyopathy) 01/2022 - 03/2015
3	Pericarditis 01/2022 - 01/2020
3	Heart Arrest (Cardiac Arrest) 01/2022 - 01/2021
3	ST Elevation Myocardial Infarction 01/2018 - 11/2014
2	Thrombosis (Thrombus) 01/2022 - 01/2018
2	Cytokine Release Syndrome 01/2021 - 01/2021
2	Hypoxia (Hypoxemia) 07/2020 - 01/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2020 - 01/2020
2	Atherosclerosis 01/2020 - 01/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2013
2	Myocarditis (Carditis) 01/2020 - 02/2014
2	Alzheimer Disease (Alzheimer's Disease) 01/2018 - 08/2014
1	Coronary Disease (Coronary Heart Disease) 01/2022
1	Neurologic Manifestations (Neurological Manifestations) 01/2022
1	Brain Ischemia (Cerebral Ischemia) 11/2021
1	Brain Edema (Cerebral Edema) 11/2021
1	Ventricular Fibrillation 11/2021
1	Anterior Wall Myocardial Infarction 06/2021
1	Lung Injury 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	COVID-19 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Cicatrix (Scar) 01/2020
1	Sarcoidosis (Schaumann Disease) 01/2019
1	Granuloma 01/2019
1	Body Weight (Weight, Body) 12/2018

Drug/Important Bio-Agent (IBA)

28	InflammasomesIBA 01/2022 - 12/2011
14	Interleukin-1 (Interleukin 1)IBA 01/2022 - 04/2009
9	CytokinesIBA 01/2022 - 02/2010
6	Proteins (Proteins, Gene)FDA Link 02/2021 - 12/2011
5	Troponin IIBA 01/2022 - 04/2014
5	dicarboxydine (DCD)IBA 01/2022 - 01/2020
5	Interleukin-18 (Interleukin 18)IBA 02/2021 - 04/2014
5	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020 - 04/2009
4	InterleukinsIBA 11/2021 - 11/2014
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020 - 01/2011
4	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 01/2019 - 10/2017
3	Leucine (L-Leucine)FDA Link 02/2021 - 01/2019
3	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2020 - 09/2009
3	alpha 1-Antitrypsin (alpha 1 Antitrypsin)IBA 01/2018 - 01/2015
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022 - 11/2021
2	AnthracyclinesIBA 01/2022 - 01/2013
2	Colchicine FDA LinkGeneric 01/2022 - 02/2021
2	dapansutrileIBA 06/2021 - 01/2019
2	AlarminsIBA 02/2021 - 01/2019
2	ZymosanIBA 02/2021 - 06/2014
2	NLR ProteinsIBA 10/2020 - 04/2016
2	CalciumIBA 01/2020 - 01/2020
2	sodium sulfideIBA 01/2020 - 06/2014
2	rilonacept FDA Link 01/2020 - 02/2010
2	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 04/2014
2	RelaxinIBA 05/2017 - 01/2016
2	Pharmaceutical PreparationsIBA 05/2017 - 06/2012
2	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2015 - 01/2013
2	LipopolysaccharidesIBA 02/2015 - 06/2014
2	C-Reactive ProteinIBA 01/2015 - 11/2014
2	Adenosine Triphosphate (ATP)IBA 06/2014 - 12/2011
2	5- quinoxalin- 6- ylmethylenethiazolidine- 2,4- dioneIBA 12/2010 - 07/2010
1	Coloring Agents (Dyes)IBA 01/2022
1	C.I. direct red 80IBA 01/2022
1	Interleukin-1 Type I ReceptorsIBA 01/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022
1	Krebs-Henseleit solutionIBA 01/2022
1	Phosphopyruvate Hydratase (Enolase)IBA 11/2021
1	Adrenergic Agents (Adrenergic Drugs)IBA 06/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 07/2020
1	BuffersIBA 01/2020
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2020
1	CatecholaminesIBA 01/2020
1	Protons (Proton)IBA 01/2020
1	Cofilin 2IBA 01/2020
1	canakinumab FDA Link 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2019
1	CC ChemokinesIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018

Therapy/Procedure

7	Therapeutics 01/2021 - 04/2014
6	Heart Transplantation (Grafting, Heart) 01/2021 - 06/2016
5	Transplantation 01/2022 - 06/2016
5	Ligation 06/2021 - 07/2014
2	Resuscitation 01/2022 - 11/2021
2	Artificial Respiration (Mechanical Ventilation) 11/2021 - 01/2021
1	Radiotherapy 01/2020
1	Stents 01/2018
1	Drug-Eluting Stents 01/2018